Research output

Research output per year 1981 2000 2023 2025

• 27 Article
• 3 Comment/debate
• 2 Review article
• 1 Editorial
• 1 More
  • 1 Letter

Research output per year

Research output per year

Search results

• 2023

  Corrigendum to “The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.” Kidney Int. 2021;100:225–237 (Kidney International (2021) 100(1) (225–237), (S0085253820314186), (10.1016/j.kint.2020.10.046))

  312 Study Group, Jul 2023, In: Kidney International. 104, 1, p. 205 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  • Kidney 100%
  • Nave 100%
  • Pediatric Patients 100%
  • Inhibitor Treatment 100%
  • Atypical Hemolytic Uremic Syndrome (aHUS) 100%

• Ethical Concerns for Amnioinfusions to Treat Early-Onset Anhydramnios

  Soffer, O. D., Mauch, T. J. & Muff-Luett, M. A., Jun 13 2023, In: JAMA. 329, 22, p. 1913-1914 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review
  5 Scopus citations
• 2005

  Erratum: Ubiquitous GFP expression in transgenic chickens using a lentiviral vector (Development vol. 132 (935-940))

  Chapman, S. C., Lawson, A., MacArthur, W. C., Wiese, R. J., Loechel, R. H., Burgos-Trinidad, M., Wakefield, J. K., Ramabhadran, R., Mauch, T. J. & Shoenwolf, G. C., Mar 2005, In: Development. 132, 5, p. 1163 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review